# DCTN1

## Overview
The DCTN1 gene encodes the protein dynactin subunit 1, also known as p150 Glued, which is a critical component of the dynactin complex. This complex plays a pivotal role in cellular processes by facilitating the function of the motor protein dynein, particularly in retrograde axonal transport along microtubules. The p150 Glued protein is characterized by its structural domains, including a CAP-Gly domain essential for microtubule binding, and coiled coil regions that contribute to its interaction with other components of the dynactin complex (ReckPeterson2018The; Schroer2004DYNACTIN). DCTN1 is involved in various cellular functions, such as vesicle transport, organelle positioning, and spindle assembly, and plays a significant role in osteoclastogenesis and neurodegenerative disease pathways (Lee2020The; Kobayashi2017Dynactin). Mutations in DCTN1 have been implicated in several neurodegenerative disorders, highlighting its clinical significance in maintaining neuronal health and function (KuźmaKozakiewicz2013Dynactin; Hwang2016Distal).

## Structure
The DCTN1 gene encodes the p150 Glued protein, the largest subunit of the dynactin complex, which is essential for dynein function. The p150 Glued protein is predicted to form an elongated dimer with two central coiled coils, approximately 50 nm and 20 nm in length, interspersed with regions of undefined structure (Schroer2004DYNACTIN). The N-terminal region of p150 Glued contains a CAP-Gly domain, crucial for microtubule binding, located within the first 110 amino acids (Schroer2004DYNACTIN). This domain is essential for linking the dynactin complex to microtubules and enhancing the processivity of the dynein motor (Schroer2004DYNACTIN).

The p150 Glued protein also includes a globular domain and two coiled coil regions (CC1 and CC2) that are part of a flexible extension from the shoulder domain of the dynactin complex (ReckPeterson2018The). The C-terminal region of p150 Glued is involved in binding interactions with the Arp1 rod, a component of the dynactin complex (Schroer2004DYNACTIN). The primary transcript of p150 Glued produces several alternately spliced mRNAs, including a neuronal isoform lacking the CAP-Gly domain (Schroer2004DYNACTIN).

## Function
The DCTN1 gene encodes the largest subunit of the dynactin complex, known as p150 Glued, which is crucial for the function of the dynein/dynactin complex in healthy human cells. This complex is involved in retrograde axonal transport along microtubules, facilitating the movement of cargo over long distances within the cell, which is essential for the normal function of motor neurons (KuźmaKozakiewicz2013Dynactin). DCTN1 interacts with dynein, a motor protein, to enhance its processivity and facilitate intracellular transport functions, including vesicle transport, organelle positioning, and spindle assembly (Kobayashi2017Dynactin; Dutta2019Role).

DCTN1 is also involved in osteoclastogenesis, the process of bone resorption by osteoclasts, through the RANKL signaling-mediated Cdc42/PAK2 pathway. It activates Cdc42, which regulates various cellular events by interacting with effector molecules like PAKs, and is involved in MAPK signaling, cell survival, and cytoskeleton reorganization (Lee2020The). The protein is active in the cytoplasm, particularly near the microtubule organizing center, and plays a role in maintaining cellular homeostasis and proper distribution of the dynein-dynactin complex throughout the cell cycle (Kobayashi2017Dynactin).

## Clinical Significance
Mutations in the DCTN1 gene, which encodes the largest subunit of the dynactin complex, are linked to several neurodegenerative diseases. These include distal hereditary motor neuropathy type 7B (dHMN7B), Perry syndrome, amyotrophic lateral sclerosis (ALS), and ALS-frontotemporal dementia (ALS/FTD) (KuźmaKozakiewicz2013Dynactin; Hwang2016Distal). dHMN7B is characterized by symptoms such as respiratory difficulties, progressive facial weakness, and muscle atrophy in the hands, often due to mutations like the p.G59S substitution (Hwang2016Distal). Perry syndrome presents with Parkinsonism, psychiatric changes, weight loss, and abnormal hypoventilation, and is associated with mutations that cluster in exon two of the DCTN1 gene (Stoker2022DCTN1).

In ALS, DCTN1 mutations disrupt axonal transport, leading to motor neuron degeneration. This is evidenced by altered DCTN1-mRNA expression in the motor cortex of sporadic ALS patients, although protein levels remain unchanged, suggesting a disruption in axonal transport (KuźmaKozakiewicz2013Dynactin). Additionally, a novel splice site variant in DCTN1 has been linked to psychiatric disorders such as bipolar disorder, potentially due to its impact on neuronal autophagy and axonal transport (Hallen2020A).

## Interactions
DCTN1, a key component of the dynactin complex, is involved in various protein interactions essential for its function in intracellular transport. The p150 subunit of DCTN1 interacts with the dynein intermediate chain, facilitating the linkage of dynein to its cargo (Kardon2009Regulators). It also binds to microtubule plus end-binding proteins such as end binding 1 (EB1) and CAP-Gly domain-containing linker protein 170 (CLIP170), which are crucial for the localization and function of dynein at microtubule plus ends (Kardon2009Regulators).

DCTN1 interacts with regulatory GTPases, including the sAR1 GTPase-activating protein SEC23 and Rab-interacting lysosomal protein (RILP), which are important for vesicle trafficking and endosome transport (Kardon2009Regulators). In osteoclastogenesis, DCTN1 interacts with the Rho family GTPase Cdc42, playing a role in cytoskeletal rearrangement and osteoclast differentiation (Lee2020The).

In the context of neurodegenerative diseases, DCTN1 is involved in the regulation of stress granule dynamics and interacts with other components of microtubule-associated motor protein complexes, such as dynein and kinesin, to prevent TDP-43 aggregation (Ueda2024Dysregulation). These interactions highlight DCTN1's critical role in cellular transport and signaling pathways.


## References


[1. (Lee2020The) Yong Deok Lee, Bongjun Kim, Suhan Jung, Haemin Kim, Min Kyung Kim, Jun-Oh Kwon, Min-Kyoung Song, Zang Hee Lee, and Hong-Hee Kim. The dynactin subunit dctn1 controls osteoclastogenesis via the cdc42/pak2 pathway. Experimental &amp; Molecular Medicine, 52(3):514–528, March 2020. URL: http://dx.doi.org/10.1038/s12276-020-0406-0, doi:10.1038/s12276-020-0406-0. This article has 10 citations.](https://doi.org/10.1038/s12276-020-0406-0)

2. (Kobayashi2017Dynactin) Dynactin has two antagonistic regulatory domains and exerts opposing effects on dynein motility. This article has 0 citations.

[3. (Kardon2009Regulators) Julia R. Kardon and Ronald D. Vale. Regulators of the cytoplasmic dynein motor. Nature Reviews Molecular Cell Biology, 10(12):854–865, December 2009. URL: http://dx.doi.org/10.1038/nrm2804, doi:10.1038/nrm2804. This article has 511 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/nrm2804)

[4. (KuźmaKozakiewicz2013Dynactin) Magdalena Kuźma-Kozakiewicz, Agnieszka Chudy, Beata Kaźmierczak, Dorota Dziewulska, Ewa Usarek, and Anna Barańczyk-Kuźma. Dynactin deficiency in the cns of humans with sporadic als and mice with genetically determined motor neuron degeneration. Neurochemical Research, 38(12):2463–2473, September 2013. URL: http://dx.doi.org/10.1007/s11064-013-1160-7, doi:10.1007/s11064-013-1160-7. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11064-013-1160-7)

[5. (Hwang2016Distal) Sun Hee Hwang, Eun Ja Kim, Young Bin Hong, Jaesoon Joo, Sung Min Kim, Soo Hyun Nam, Hyun Dae Hong, Seung Hyun Kim, Kiwook Oh, Jeong-Geun Lim, Jeong Hee Cho, Ki Wha Chung, and Byung-Ok Choi. Distal hereditary motor neuropathy type 7b with dynactin 1 mutation. Molecular Medicine Reports, 14(4):3362–3368, August 2016. URL: http://dx.doi.org/10.3892/mmr.2016.5664, doi:10.3892/mmr.2016.5664. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2016.5664)

[6. (Dutta2019Role) Rajib Dutta and Swatilekha Roy Sarkar. Role of dynein and dynactin (dctn-1) in neurodegenerative diseases. Neurophysiology and Rehabilitation, pages 53–58, December 2019. URL: http://dx.doi.org/10.33805/2641-8991.123, doi:10.33805/2641-8991.123. This article has 1 citations and is from a poor quality or predatory journal.](https://doi.org/10.33805/2641-8991.123)

[7. (Ueda2024Dysregulation) Tetsuhiro Ueda, Toshihide Takeuchi, Nobuhiro Fujikake, Mari Suzuki, Eiko N. Minakawa, Morio Ueyama, Yuzo Fujino, Nobuyuki Kimura, Seiichi Nagano, Akio Yokoseki, Osamu Onodera, Hideki Mochizuki, Toshiki Mizuno, Keiji Wada, and Yoshitaka Nagai. Dysregulation of stress granule dynamics by dctn1 deficiency exacerbates tdp-43 pathology in drosophila models of als/ftd. Acta Neuropathologica Communications, February 2024. URL: http://dx.doi.org/10.1186/s40478-024-01729-8, doi:10.1186/s40478-024-01729-8. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s40478-024-01729-8)

[8. (ReckPeterson2018The) Samara L. Reck-Peterson, William B. Redwine, Ronald D. Vale, and Andrew P. Carter. The cytoplasmic dynein transport machinery and its many cargoes. Nature Reviews Molecular Cell Biology, 19(6):382–398, April 2018. URL: http://dx.doi.org/10.1038/s41580-018-0004-3, doi:10.1038/s41580-018-0004-3. This article has 506 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41580-018-0004-3)

[9. (Stoker2022DCTN1) Thomas B. Stoker, Vaclav Dostal, Jeffrey Cochius, Caroline H. Williams-Gray, Clemens R. Scherzer, Junhao Wang, Ganqiang Liu, and Ian Coyle-Gilchrist. Dctn1 mutation associated parkinsonism: case series of three new families with perry syndrome. Journal of Neurology, 269(12):6667–6672, July 2022. URL: http://dx.doi.org/10.1007/s00415-022-11308-3, doi:10.1007/s00415-022-11308-3. This article has 2 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00415-022-11308-3)

[10. (Hallen2020A) André Hallen and Arthur J. L. Cooper. A novel cosegregating dctn1 splice site variant in a family with bipolar disorder may hold the key to understanding the etiology. Genes, 11(4):446, April 2020. URL: http://dx.doi.org/10.3390/genes11040446, doi:10.3390/genes11040446. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes11040446)

[11. (Schroer2004DYNACTIN) Trina A. Schroer. Dynactin. Annual Review of Cell and Developmental Biology, 20(1):759–779, November 2004. URL: http://dx.doi.org/10.1146/annurev.cellbio.20.012103.094623, doi:10.1146/annurev.cellbio.20.012103.094623. This article has 565 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1146/annurev.cellbio.20.012103.094623)